• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Third Rock and Takeda Fund $140 Million Startup to Create Regenerative Therapies for Liver...

cafead

Administrator
Staff member
  • cafead   Aug 08, 2018 at 09:42: AM
via Ambys Medicines launched on 8/8/18 with a $60 million Series A financing funded by Third Rock Ventures and Takeda. As part of the launch, Ambys also announced today a strategic partnership with Takeda bringing total committed funding at launch to $140 million.

article source
 

<